Brief: ABIONYX Pharma FY Operating Cash Flow EUR -2.9 Million
12/03/2026 17:00
Mar 12 (Reuters) - ABIONYX Pharma FY EBIT EUR -5.5 million. FY net income EUR -5.5 million
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls